Opportunity In The Operating Room
With the global operating room equipment market surpassing $29 billion in 2018, and expected to see year-over-year growth of 6% this year, rising operating room… Read More »Opportunity In The Operating Room
Health Stocks
A Women’s Health Stock Analysts (And Insiders) Are Loving, But The Market Is Ignoring
With drug candidates in clinical development for in vitro fertilization, endometriosis and more, this Swiss-based, clinical-stage biopharma company is focused on the creation and commercialization… Read More »A Women’s Health Stock Analysts (And Insiders) Are Loving, But The Market Is Ignoring
Healthcare Stocks: Business Over Breakthrough
When it comes to finding sources of strong returns among healthcare stocks, investors may be better off focusing on businesses rather than potential breakthroughs. In… Read More »Healthcare Stocks: Business Over Breakthrough
Healthcare Stocks With Political Immunity
Healthcare stocks have lagged overall this year, in large part due to political and regulatory risks. Some healthcare stocks, however, appear to be shielded from… Read More »Healthcare Stocks With Political Immunity
Monster Upside Potential At Minuscule Prices
An “off-the-radar” marijuana play and a microcap medical company whose lead product candidate is a low-dose, once-weekly hormonal contraceptive patch are among five stocks currently… Read More »Monster Upside Potential At Minuscule Prices
Are Healthcare Stocks Contraindicated?
Most of the presidential contenders from one of the country’s two main political parties support Medicare for All – and while several Wall Street analysts… Read More »Are Healthcare Stocks Contraindicated?
Significant Upside At A Healthy Discount
Talk of “Medicare For All” and other dramatic changes to the American health care system from 2020 presidential contenders has not been healthy for health… Read More »Significant Upside At A Healthy Discount
Therapeutic Trifecta
With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one… Read More »Therapeutic Trifecta
Biotech Is On The Mend
After finding itself among the most oversold sectors last year, biotech is having its best start to a year since 2012 – a rally fueled… Read More »Biotech Is On The Mend
How Dr. Amazon Is Making The Rounds
Over the past year, Amazon has made some ambitious moves into the $3.5 trillion health care sector – and it’s likely just getting started. Here’s… Read More »How Dr. Amazon Is Making The Rounds